Luminoma Diagnostics

Luminoma Diagnostics

Private
AucklandHealthcare & Life Scienceshttps://luminomadx.com

Last Round

Early Funding

Aug 13, 2025

Total Funding Raised

$3.79M

Company Overview

Luminoma Diagnostics is a diagnostic equipment company that is developing a portable, non-invasive device using Raman spectroscopy and machine learning to aid clinicians in the early detection of skin cancer.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Sensors, Medical AI, Medical Imaging

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Application

Keywords

skin cancer diagnosticsRaman spectroscopynon-invasive diagnosticsmedical AIoptical biopsypoint-of-care diagnosticsdiagnostic aidlesion assessmentmolecular diagnosticsdermatology toolsbiopsy reductionPOC testingmedical devicehardware as a serviceHaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Luminoma Diagnostics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Luminoma Diagnostics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early FundingAug 13, 2025
SeedJun 6, 2024

Key People

Founding team and executive leadership

Maher Khaled

CEO

Executive Team

Luminoma Diagnostics Investors

Notable investors and investment history

InvestorRounds
Catalist Nominee LimitedEarly Funding
Bridgewest VenturesEarly Funding, Seed
Pacific ChannelEarly Funding, Seed

Luminoma Diagnostics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Luminoma Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Luminoma Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersAuckland
Employee Range7
Year Founded2023
Last FundingAug 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.